Dr Tamara L Kaufman, PHARM D in Elgin, NE - Pharmacist

Dr Tamara L Kaufman, PHARM D is a Pharmacist based in Elgin, Nebraska. Dr Tamara L Kaufman is licensed to practice in Nebraska (license number 12817) and her current practice location is 112 S 2nd St, Elgin, Nebraska. She can be reached at her office (for appointments etc.) via phone at (402) 843-5555.

NPI number for Dr Tamara L Kaufman is 1629202932 and her current mailing address is 112 S 2nd St, Po Box 429, Elgin, Nebraska. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1629202932.

Contact Information

	Dr Tamara L Kaufman, PHARM D
	112 S 2nd St, Elgin, NE 68636-4409
	(402) 843-5555
	Not Available

Healthcare Provider's Profile

Full Name	Dr Tamara L Kaufman
Gender	Female
Speciality	Pharmacist
Location	112 S 2nd St, Elgin, Nebraska
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1629202932
Provider Enumeration Date: 05/14/2009
Last Update Date: 05/14/2009

Medical Identifiers

Medical identifiers for Dr Tamara L Kaufman such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1629202932	NPI	-	NPPES
10025557800	Medicaid	NE

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	12817 (Nebraska)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Tamara L Kaufman is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Tamara L Kaufman, PHARM D 112 S 2nd St, Po Box 429, Elgin, NE 68636-4409 Ph: (402) 843-5555	Dr Tamara L Kaufman, PHARM D 112 S 2nd St, Elgin, NE 68636-4409 Ph: (402) 843-5555

News Archive

Mechanism blocking HIV-1 from entering cells identified

Publishing in PLoS Pathogens, researchers at from the Kimmel Cancer Center at Jefferson have found a novel mechanism by which drugs block HIV-1 from entering host cells.

Chronix' DNA blood tests detect prostate, breast cancer with 92% sensitivity and 100% specificity

Chronix Biomedical today reported new data further demonstrating that its DNA blood tests have the potential to accurately detect early stage breast and prostate cancers. Chronix's proprietary technology identifies disease-specific genetic fingerprints based on DNA fragments that are released into the bloodstream by damaged and dying (apoptotic) cells.

HLA-Cw*0602 gene variation detected as a high risk for psoriasis

A specific genetic region that has been increasingly identified as the strongest genetic link to psoriasis has an even more significant role in the chronic skin disease than has been suspected, University of Utah medical researchers show in a new study.

Victoria agrees to National Health Performance Authority

It is Australia's turn to get a new National Health Performance Authority after the Victorian Government abandoned its opposition to the creation of the body. According to sources in a meeting of federal, state and territory health ministers in Melbourne this week all groups have agreed in principle to the establishment of the authority which will monitor and report on the performance of hospitals and health services.

Dr Tamara L Kaufman, PHARM D - Pharmacist in Elgin, NE